Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Intent to Accept a Valley Fever Vaccine for Humans and Dogs and Factors Influencing Intended Uptake: A Cross-Sectional Survey in Two Endemic Regions.

Journal of fungi (Basel, Switzerland)·2026

Same author

Exhausted T cell phenotypes in disseminated coccidioidomycosis.

JCI insight·2026

Same author

Th2 skewing in patients with disseminated coccidioidomycosis.

JCI insight·2026

Same author

Exhausted T cell phenotypes in disseminated coccidioidomycosis.

medRxiv : the preprint server for health sciences·2026

Same author

The Use of Genetics and Immunology in the Diagnosis and Care of Advanced Coccidioidomycosis: Where Are We Going?

Journal of fungi (Basel, Switzerland)·2025

Same author

Managing Cavitary Coccidioidomycosis Expert Opinions for Improving Patient Outcomes.

Chest·2024

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Pulmonary coccidioidomycosis.

Irene M Spinello¹, Augustine Munoz, Royce H Johnson

¹Department of Medicine, Kern Medical Center, Bakersfield, California 93305, USA. spinelloi@kernmedctr.com

Seminars in Respiratory and Critical Care Medicine

|March 28, 2008

Summary

This summary is machine-generated.

Coccidioidal infection primarily affects the lungs, with most cases being asymptomatic. Symptomatic infections can range from mild flu-like illness to severe pneumonia, requiring specific management strategies.

More Related Videos

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Published on: December 13, 2024

Related Experiment Videos

Last Updated: Jul 6, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Published on: December 13, 2024

Area of Science:

Medical Mycology
Pulmonology
Infectious Diseases

Background:

Coccidioidal infection, caused by inhaling airborne arthroconidia, commonly presents as pulmonary disease.
Pulmonary coccidioidomycosis is categorized into primary, complicated, and residual forms.
While 60% of infections are asymptomatic, 40% develop symptomatic disease with diverse presentations.

Purpose of the Study:

To review the classification and management of pulmonary coccidioidomycosis.
To discuss uncomplicated and complicated forms of the disease.
To address special considerations including fungemia, pregnancy, and organ transplantation.

Main Methods:

Literature review focusing on coccidioidal infection.
Analysis of primary, complicated, and residual pulmonary coccidioidomycosis.
Inclusion of special populations and complications.

Main Results:

Pulmonary coccidioidomycosis encompasses primary, complicated (e.g., severe pneumonia, ARDS), and residual (nodule, fibrosis) categories.
Symptomatic disease often mimics influenza or pneumonia.
Complicated forms include severe pneumonia, fibrocavitary disease, and empyema.

Conclusions:

Effective management of pulmonary coccidioidomycosis depends on accurate classification into primary, complicated, or residual disease.
Special populations like pregnant individuals and transplant recipients require tailored approaches.
Understanding the spectrum of coccidioidal infection is crucial for patient outcomes.